PROGRAM EVALUATION

*
*
*
*
*
*
*
Strongly agreeAgreeNeutralDisagreeStrongly disagree
Discuss the latest insights into RA immunopathology with a focus on Janus kinase (JAK) enzyme activation
Evaluate patients with RA longitudinally based on an understanding of treat-to-target recommendations and appropriate disease activity measures
Describe the mechanistic profiles and clinical trial data for current and emerging targeted synthetic disease-modifying antirheumatic drugs (DMARDs)
Integrate targeted synthetic DMARDs into treatment regimens for patients with RA based on current clinical practice guidelines and evidence for efficacy and safety
*
*
*
Strongly agreeAgreeNeutralDisagree stronglyDisagree
The faculty was knowledgeable and effective
The content presented was relevant and enhanced my knowledge base
The activity provided useful tools that will improve patient care and enhance my professional practice
The teaching and learning methods were effective
As a result of this activity, I intend to change my practice within the next 6 months
I am more confident in my ability to manage my patients with RA after participating in this activity
*
*
*
*
*